250 related articles for article (PubMed ID: 33676027)
21. Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency.
Sadat R; Barca E; Masand R; Donti TR; Naini A; De Vivo DC; DiMauro S; Hanchard NA; Graham BH
Mol Genet Metab; 2016 May; 118(1):28-34. PubMed ID: 26992325
[TBL] [Abstract][Full Text] [Related]
22. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
23. TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer.
Yang M; Huang Q; Li C; Jiang Z; Sun J; Wang Z; Liang R; Li D; Li B; Zhao H
Front Immunol; 2021; 12():647540. PubMed ID: 33897695
[TBL] [Abstract][Full Text] [Related]
24. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
[TBL] [Abstract][Full Text] [Related]
25. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
26. MiR-346-5p promotes colorectal cancer cell proliferation in vitro and in vivo by targeting FBXL2 and activating the β-catenin signaling pathway.
Pan S; Wu W; Ren F; Li L; Li Y; Li W; Wang A; Liu D; Dong Y
Life Sci; 2020 Mar; 244():117300. PubMed ID: 31953162
[TBL] [Abstract][Full Text] [Related]
27. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
28. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
[TBL] [Abstract][Full Text] [Related]
30. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids
Liu G; Kuang S; Cao R; Wang J; Peng Q; Sun C
FASEB J; 2019 Sep; 33(9):10089-10103. PubMed ID: 31199678
[TBL] [Abstract][Full Text] [Related]
31. Loss of AKR1B10 promotes colorectal cancer cells proliferation and migration via regulating FGF1-dependent pathway.
Yao Y; Wang X; Zhou D; Li H; Qian H; Zhang J; Jiang L; Wang B; Lin Q; Zhu X
Aging (Albany NY); 2020 Jul; 12(13):13059-13075. PubMed ID: 32615540
[TBL] [Abstract][Full Text] [Related]
32. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer.
Liu RT; Wang GR; Liu C; Qiu J; Yan LK; Li XJ; Wang XQ
Int J Mol Med; 2016 Sep; 38(3):703-12. PubMed ID: 27430286
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA LINC01234 promoted cell proliferation and invasion via miR-1284/TRAF6 axis in colorectal cancer.
Liao X; Zhan W; Zhang J; Cheng Z; Li L; Tian T; Yu L; Li R
J Cell Biochem; 2020 Oct; 121(10):4295-4309. PubMed ID: 31904146
[TBL] [Abstract][Full Text] [Related]
34. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
35. MICAL1 inhibits colorectal cancer cell migration and proliferation by regulating the EGR1/β-catenin signaling pathway.
Gu H; Li Y; Cui X; Cao H; Hou Z; Ti Y; Liu D; Gao J; Wang Y; Wen P
Biochem Pharmacol; 2022 Jan; 195():114870. PubMed ID: 34902339
[TBL] [Abstract][Full Text] [Related]
36. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy.
Roongta UV; Pabalan JG; Wang X; Ryseck RP; Fargnoli J; Henley BJ; Yang WP; Zhu J; Madireddi MT; Lawrence RM; Wong TW; Rupnow BA
Mol Cancer Res; 2011 Nov; 9(11):1551-61. PubMed ID: 21954435
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
Wu Y; Song Y; Xiong Y; Wang X; Xu K; Han B; Bai Y; Li L; Zhang Y; Zhou L
Cell Physiol Biochem; 2017; 43(3):945-958. PubMed ID: 28957811
[TBL] [Abstract][Full Text] [Related]
38. BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.
Zhu GD; Liu F; OuYang S; Zhou R; Jiang FN; Zhang B; Liao WJ
Biochem Biophys Res Commun; 2018 May; 499(2):120-127. PubMed ID: 29481800
[TBL] [Abstract][Full Text] [Related]
39. Lipid metabolism in colon cancer: Role of Liver X Receptor (LXR) and Stearoyl-CoA Desaturase 1 (SCD1).
Piccinin E; Cariello M; Moschetta A
Mol Aspects Med; 2021 Apr; 78():100933. PubMed ID: 33218679
[TBL] [Abstract][Full Text] [Related]
40. Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells.
Wang Z; Kang B; Gao Q; Huang L; Di J; Fan Y; Yu J; Jiang B; Gao F; Wang D; Sun H; Gu Y; Li J; Su X
Cancer Sci; 2021 Sep; 112(9):3895-3910. PubMed ID: 34185934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
